Isabel Siegle
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Inflammatory mediators and NSAID effects 7
- Pharmacogenetics and Drug Metabolism 4
-
- Plant tissue culture and regeneration 2
- Co-authors
- Péter Fritz (9 shared papers)Thomas Klein (5 shared papers)Janne T. Backman (4 shared papers)Ulrich M. Zanger (4 shared papers)J. G. Saal (2 shared papers)Michel Eichelbaum (1 shared paper)Klaus Eckhardt (1 shared paper)Péter Fritz (1 shared paper)
- Journals
- Advances in experimental medicine and biology (1 paper)FEBS Letters (1 paper)Journal of Clinical Oncology (1 paper)Journal of Histochemistry & Cytochemistry (1 paper)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (1 paper)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Isabel Siegle
18 papers receiving 527 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 144
- Biochemistry 99
- Pharmacology 183
- Rheumatology 70
- Immunology 84
Countries citing papers authored by Isabel Siegle
This map shows the geographic impact of Isabel Siegle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Siegle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Siegle more than expected).
Fields of papers citing papers by Isabel Siegle
This network shows the impact of papers produced by Isabel Siegle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Siegle. The network helps show where Isabel Siegle may publish in the future.
Co-authors
The 25 scholars most cited alongside Isabel Siegle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 173 | |
| 2 | 2001 | 119 | |
| 3 | 2001 | 45 | |
| 4 | Combined cytotoxic action of Viscum album agglutinin-1 and anticancer agents against human A549 lung cancer cells. | 2001 | 43 |
| 5 | 2000 | 29 | |
| 6 | 1992 | 28 | |
| 7 | 2001 | 18 | |
| 8 | 1994 | 17 | |
| 9 | 1999 | 15 | |
| 10 | Impact of mistletoe lectin binding in breast cancer. | 2004 | 15 |
| 11 | 1998 | 13 | |
| 12 | 2015 | 9 | |
| 13 | 1997 | 6 | |
| 14 | 1999 | 4 | |
| 15 | 1998 | 4 | |
| 16 | 1995 | 2 | |
| 17 | 2001 | 2 | |
| 18 | 2001 | 1 | |
| 19 | 2001 | 0 |
About Isabel Siegle
Isabel Siegle is a scholar working on Pharmacology, Molecular Biology, Pharmacology, Immunology and Genetics, having authored 19 papers that have together received 543 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Toxin Mechanisms and Immunotoxins (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Estrogen and related hormone effects (3 papers), Transgenic Plants and Applications (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Plant tissue culture and regeneration (2 papers). The work is most often cited by research in Pharmacology (144 citations), Biochemistry (99 citations), Pharmacology (183 citations), Rheumatology (70 citations) and Immunology (84 citations). Isabel Siegle has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Péter Fritz, Thomas Klein, Janne T. Backman, Ulrich M. Zanger, J. G. Saal, Michel Eichelbaum, Klaus Eckhardt, Péter Fritz, Thomas E. Mürdter and Péter Fritz. Their work appears in journals such as Advances in experimental medicine and biology, FEBS Letters, Journal of Clinical Oncology, Journal of Histochemistry & Cytochemistry and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.